View in EDS HTML Full Text PDF Full Text

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Saved in:
Bibliographic Details
Title: Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Authors: Levitt JE; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Hedlin H; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Duong S; Stanford Center for Clinical Research, Stanford, CA, USA., Lu D; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Lee J; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Bunning B; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Elkarra N; Stanford Center for Clinical Research, Stanford, CA, USA., Pinsky BA; Department of Pathology Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Heffernan E; Celltaxis LLC, Atlanta, GA, USA., Springman E; Celltaxis LLC, Atlanta, GA, USA., Moss RB; Pediatrics (Pulmonary Medicine), Center for Excellence in Pulmonary Biology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Bonilla HF; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Parsonnet J; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Zamanian RT; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Langguth JJ; Stanford Center for Clinical Research, Stanford, CA, USA., Bollyky J; Stanford Innovative Medicines Accelerator, Stanford, CA, USA., Khosla C; Stanford Innovative Medicines Accelerator, Stanford, CA, USA., Nicolls MR; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Desai M; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Rogers AJ; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 26; Vol. 77 (2), pp. 186-193.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36996150
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Levitt+JE%22">Levitt JE</searchLink>; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hedlin+H%22">Hedlin H</searchLink>; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Duong+S%22">Duong S</searchLink>; Stanford Center for Clinical Research, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+D%22">Lu D</searchLink>; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bunning+B%22">Bunning B</searchLink>; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Elkarra+N%22">Elkarra N</searchLink>; Stanford Center for Clinical Research, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pinsky+BA%22">Pinsky BA</searchLink>; Department of Pathology Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Heffernan+E%22">Heffernan E</searchLink>; Celltaxis LLC, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Springman+E%22">Springman E</searchLink>; Celltaxis LLC, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Moss+RB%22">Moss RB</searchLink>; Pediatrics (Pulmonary Medicine), Center for Excellence in Pulmonary Biology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bonilla+HF%22">Bonilla HF</searchLink>; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Parsonnet+J%22">Parsonnet J</searchLink>; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zamanian+RT%22">Zamanian RT</searchLink>; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Langguth+JJ%22">Langguth JJ</searchLink>; Stanford Center for Clinical Research, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bollyky+J%22">Bollyky J</searchLink>; Stanford Innovative Medicines Accelerator, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Khosla+C%22">Khosla C</searchLink>; Stanford Innovative Medicines Accelerator, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nicolls+MR%22">Nicolls MR</searchLink>; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Desai+M%22">Desai M</searchLink>; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rogers+AJ%22">Rogers AJ</searchLink>; Division of Pulmonary, Allergy, and Critical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2023 Jul 26; Vol. 77 (2), pp. 186-193.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36996150
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciad187
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 186
    Titles:
      – TitleFull: Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Levitt JE
      – PersonEntity:
          Name:
            NameFull: Hedlin H
      – PersonEntity:
          Name:
            NameFull: Duong S
      – PersonEntity:
          Name:
            NameFull: Lu D
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Bunning B
      – PersonEntity:
          Name:
            NameFull: Elkarra N
      – PersonEntity:
          Name:
            NameFull: Pinsky BA
      – PersonEntity:
          Name:
            NameFull: Heffernan E
      – PersonEntity:
          Name:
            NameFull: Springman E
      – PersonEntity:
          Name:
            NameFull: Moss RB
      – PersonEntity:
          Name:
            NameFull: Bonilla HF
      – PersonEntity:
          Name:
            NameFull: Parsonnet J
      – PersonEntity:
          Name:
            NameFull: Zamanian RT
      – PersonEntity:
          Name:
            NameFull: Langguth JJ
      – PersonEntity:
          Name:
            NameFull: Bollyky J
      – PersonEntity:
          Name:
            NameFull: Khosla C
      – PersonEntity:
          Name:
            NameFull: Nicolls MR
      – PersonEntity:
          Name:
            NameFull: Desai M
      – PersonEntity:
          Name:
            NameFull: Rogers AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 07
              Text: 2023 Jul 26
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 77
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1